Cover Image
市場調查報告書

骨移植、替代骨:開發平台分析

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 344260
出版日期 內容資訊 英文 356 Pages
訂單完成後即時交付
價格
Back to Top
骨移植、替代骨:開發平台分析 Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年12月01日 內容資訊: 英文 356 Pages
簡介

本報告提供全球各國的企業、醫療機關等開發中的骨移植片及替代骨 (替代骨移植片) 的開發中產品資訊相關分析、臨床實驗/產品開發的整體進展,及各階段/各領域/各地區的詳細趨勢、各企業、各產品的詳細資訊 (臨床實驗的進展階段、開始/結束時期、認證預測等)、近來的產品開發的動向、產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 骨移植、替代骨:現在開發中的開發中產品 (各企業)

  • 骨移植、替代骨的開發企業:開發中產品 (各開發階段)
  • 骨移植、替代骨:各開發階段的開發中產品一覽

第5章 骨移植、替代骨的企業、產品概要

  • aap Implantate AG
    • 開發中產品及現在進行中的臨床實驗概要
  • Accelerated Orthopedic Technologies, Inc.
  • Adaptaide Inc.
  • Adocia
  • Advanced Biologics, LLC
  • Agenta Biotechnologies, Inc.
  • Allergan, Inc.
  • Alphatec Holdings, Inc.
  • Amedica Corporation
  • Anika Therapeutics, Inc.
  • ApaTech Limited (Inactive)
  • Aperion Biologics Corporation
  • Arthro Kinetics AG
  • Aursos, Inc
  • Berkeley Advanced Biomaterials, Inc.
  • Bio2 Technologies, Inc.
  • Bioactive Bone Substitutes Ltd.
  • Bioregeneration Technologies, Inc
  • Bio-Scaffold International Pte Ltd
  • BioSET, Inc
  • Bioventus LLC
  • Body Organ Biomedical Corp.
  • Bone Solutions, Inc.
  • BoneGrafix, Inc.
  • BoneSupport AB
  • Calcitec, Inc.
  • Cellright Technologies, LLC
  • CeraPedics, Inc.
  • Chinese University of Hong Kong
  • Citrics Biomedical, LLC
  • CollPlant Ltd.
  • ConMed Corporation
  • CoreBone Ltd.
  • ElutInc
  • EpiBone
  • Exactech, Inc.
  • Graftoss Limited
  • Graftys SAS
  • Inion Oy
  • Innovia LLC
  • Innovoss Inc.
  • Integra LifeSciences Holdings Corporation
  • ISTO Technologies, Inc.
  • Jellagen Pty Ltd
  • kasios sas
  • Kensey Nash Corporation (Inactive)
  • Kytogenics Pharmaceuticals, Inc.
  • Lacerta Technologies GmbH
  • Mariel Therapeutics, Inc.
  • Maxigen Biotech Inc.
  • Medtronic plc
  • Meta Biomed Co., Ltd.
  • Miromatrix Medical Inc.
  • N2 Biomedical
  • National Center of Innovation for Biomaterials in Orthopaedic Research
  • Noraker
  • NovaBone Products, LLC.
  • Nutech Medical, Inc
  • NuVasive, Inc.
  • Orthogen LLC
  • OssiFi, Inc.
  • OsteoNovus, LLC
  • PolyPid, Ltd.
  • Promimic AB
  • ReCaPP
  • RepRegen Ltd. (Inactive)
  • Revivicor, Inc.
  • RTI Surgical, Inc.
  • Sanofi
  • SIRAKOSS Limited
  • Soft Tissue Regeneration, Inc.
  • Soteira Inc.
  • Spineway
  • SurgaColl Technologies Ltd
  • TBF Genie Tissulaire
  • The Johns Hopkins University
  • Tissue Regeneration Systems, Inc.
  • Trinity College Dublin
  • University of California, San Diego
  • University of Edinburgh
  • University of Memphis
  • University of Nottingham's School Of Pharmacy
  • University of Pecs
  • University of South Florida
  • Wayne State University
  • Wound Management Technologies, Inc.
  • Wright Medical Group, Inc.
  • X-spine Systems, Inc.
  • Xtant Medical Holdings, Inc.

第6章 骨移植、替代骨:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0286EPD

GlobalData's Medical Devices sector report, "Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2016" provides an overview of Bone Grafts and Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Grafts and Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Grafts and Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Grafts and Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Grafts and Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 11
  • 1.2 List of Figures 21

2 Introduction 22

  • 2.1 Bone Grafts and Substitutes Overview 22

3 Products under Development 23

  • 3.1 Bone Grafts and Substitutes - Pipeline Products by Stage of Development 23
  • 3.2 Bone Grafts and Substitutes - Pipeline Products by Segment 24
  • 3.3 Bone Grafts and Substitutes - Pipeline Products by Territory 25
  • 3.4 Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 26
  • 3.5 Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 27
  • 3.6 Bone Grafts and Substitutes - Ongoing Clinical Trials 28

4 Bone Grafts and Substitutes - Pipeline Products under Development by Companies 29

  • 4.1 Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development 29
  • 4.2 Bone Grafts and Substitutes - Pipeline Products by Stage of Development 33

5 Bone Grafts and Substitutes Companies and Product Overview 37

  • 5.1 Accelerated Orthopedic Technologies, Inc. Company Overview 37
  • 5.2 Adaptaide Inc. Company Overview 38
  • 5.3 Adocia Company Overview 39
  • 5.4 Advanced Biologics LLC Company Overview 42
  • 5.5 Aeon Astron Corporation Company Overview 43
  • 5.6 Agenta Biotechnologies Inc Company Overview 44
  • 5.7 Allegra Orthopaedics Ltd Company Overview 45
  • 5.8 Allergan Inc Company Overview 47
  • 5.9 Alphatec Holdings Inc Company Overview 49
  • 5.10 Anika Therapeutics Inc Company Overview 50
  • 5.11 Antibe Therapeutics Inc Company Overview 52
  • 5.12 Aperion Biologics Corporation Company Overview 54
  • 5.13 Arthro Kinetics AG Company Overview 59
  • 5.14 Aursos, Inc (Inactive) Company Overview 60
  • 5.15 Baxter International Inc Company Overview 61
  • 5.16 Berkeley Advanced Biomaterials, Inc. Company Overview 64
  • 5.17 Bio2 Technologies, Inc. Company Overview 67
  • 5.18 Bioactive Bone Substitutes Ltd Company Overview 68
  • 5.19 Bioregeneration Technologies, Inc Company Overview 71
  • 5.20 Bio-Scaffold International Pte Ltd Company Overview 72
  • 5.21 BioSET Inc Company Overview 75
  • 5.22 Bioventus LLC Company Overview 77
  • 5.23 Bone Solutions, Inc. Company Overview 79
  • 5.24 BoneGrafix, Inc. Company Overview 83
  • 5.25 BoneSupport AB Company Overview 84
  • 5.26 Calcitec, Inc. Company Overview 89
  • 5.27 Citrics Biomedical, LLC Company Overview 90
  • 5.28 CollPlant Ltd. Company Overview 91
  • 5.29 Colorado Therapeutics, LLC Company Overview 93
  • 5.30 ConMed Corporation Company Overview 94
  • 5.31 CoreBone Ltd. Company Overview 96
  • 5.32 curasan AG Company Overview 97
  • 5.33 Daewoong Pharmaceutical Co Ltd Company Overview 101
  • 5.34 DSM Biomedical B.V. Company Overview 103
  • 5.35 Element Orthopedics, Inc. Company Overview 104
  • 5.36 ElutInc Company Overview 105
  • 5.37 Ember Therapeutics Inc Company Overview 106
  • 5.38 EpiBone Company Overview 107
  • 5.39 Exactech Inc Company Overview 108
  • 5.40 Ferring Pharmaceuticals A/S Company Overview 109
  • 5.41 Graftoss Limited Company Overview 110
  • 5.42 Graftys SAS Company Overview 111
  • 5.43 Inion Oy Company Overview 116
  • 5.44 Innovia LLC Company Overview 117
  • 5.45 Innovoss Inc. Company Overview 118
  • 5.46 Integra LifeSciences Holdings Corp Company Overview 119
  • 5.47 ISTO Technologies Inc Company Overview 120
  • 5.48 Jellagen Pty Ltd Company Overview 121
  • 5.49 John Hopkins University Company Overview 122
  • 5.50 kasios sas Company Overview 123
  • 5.51 King's College London Company Overview 125
  • 5.52 Kuros Biosciences AG Company Overview 127
  • 5.53 Kytogenics Pharmaceuticals Inc Company Overview 130
  • 5.54 Lattice Biologics Ltd Company Overview 131
  • 5.55 Maxigen Biotech Inc Company Overview 134
  • 5.56 Medisse BV Company Overview 137
  • 5.57 Medtronic plc Company Overview 138
  • 5.58 Meta Biomed Co Ltd Company Overview 142
  • 5.59 Miromatrix Medical Inc Company Overview 144
  • 5.60 N2 Biomedical Company Overview 145
  • 5.61 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 146
  • 5.62 NovaBone Products LLC Company Overview 147
  • 5.63 Nutech Medical Inc Company Overview 148
  • 5.64 NuVasive Inc Company Overview 149
  • 5.65 Orthocell Limited Company Overview 151
  • 5.66 Orthogen LLC Company Overview 154
  • 5.67 Orthosera GmbH Company Overview 155
  • 5.68 OssiFi, Inc. Company Overview 156
  • 5.69 OsteoNovus, LLC Company Overview 157
  • 5.70 PolyPid Ltd Company Overview 159
  • 5.71 Promimic AB Company Overview 161
  • 5.72 ReCaPP Company Overview 162
  • 5.73 RepRegen Ltd. (Inactive) Company Overview 163
  • 5.74 Revivicor Inc Company Overview 165
  • 5.75 RTI Surgical Inc Company Overview 166
  • 5.76 San Raffaele hospital Company Overview 168
  • 5.77 Scil Technology GmbH Company Overview 169
  • 5.78 SIRAKOSS Limited Company Overview 170
  • 5.79 Soft Tissue Regeneration Inc Company Overview 171
  • 5.80 Soteira Inc Company Overview 174
  • 5.81 SurgaColl Technologies Ltd Company Overview 175
  • 5.82 TBF Genie Tissulaire Company Overview 176
  • 5.83 The Chinese University of Hong Kong Company Overview 179
  • 5.84 Tissue Regeneration Systems, Inc. Company Overview 180
  • 5.85 Trinity College Dublin Company Overview 181
  • 5.86 University of California San Diego Company Overview 182
  • 5.87 University of Edinburgh Company Overview 183
  • 5.88 University of Memphis Company Overview 184
  • 5.89 University of Nottingham's School Of Pharmacy Company Overview 185
  • 5.90 University of Pecs Company Overview 186
  • 5.91 University of South Florida Company Overview 187
  • 5.92 Wayne State University Company Overview 188
  • 5.93 Wound Management Technologies Inc Company Overview 189
  • 5.94 Wright Medical Group NV Company Overview 190
  • 5.95 X-spine Systems, Inc. Company Overview 196
  • 5.96 Xtant Medical Holdings Inc Company Overview 197

6 Bone Grafts and Substitutes- Recent Developments 199

  • 6.1 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 199
  • 6.2 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer 201
  • 6.3 Nov 22, 2016: Amedica appoints vice president of sales and marketing 202
  • 6.4 Nov 22, 2016: Amedica Announces New Sales Leadership and Provides Regulatory Updates 202
  • 6.5 Nov 18, 2016: Cerapedics Receives Best New Technology Award For Spine Care At NASS Annual Meeting 203
  • 6.6 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 203
  • 6.7 Nov 10, 2016: Amedica Reports Third Quarter 2016 Financial Results 204
  • 6.8 Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter 205
  • 6.9 Nov 09, 2016: Cartiva Raises USD7 Million in Venture Financing 206
  • 6.10 Nov 09, 2016: Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results 206
  • 6.11 Nov 09, 2016: Athersys Reports Third Quarter 2016 Results 208
  • 6.12 Nov 08, 2016: Globus Medical Reports Third Quarter 2016 Results 209
  • 6.13 Nov 07, 2016: Novastep Launches biofit Allograft Bone Wedge System 210
  • 6.14 Nov 07, 2016: Bioventus Appoints Andrew McCartney Managing Director, International for EMEA 211
  • 6.15 Nov 07, 2016: BONESUPPORT Announces Key Corporate Appointment To Drive Growth In North America 211
  • 6.16 Nov 07, 2016: Xtant Medical Holdings Reports Record Third Quarter 2016 Results 212
  • 6.17 Nov 03, 2016: DSM Q3 2016 Results 213
  • 6.18 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 215
  • 6.19 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 216
  • 6.20 Nov 01, 2016: Xtant Medical Receives Approval of Compliance Plan from NYSE MKT 218
  • 6.21 Oct 31, 2016: Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 218
  • 6.22 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 219
  • 6.23 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 219
  • 6.24 Oct 31, 2016: Orthofix International Reports Third Quarter 2016 Financial Results 221
  • 6.25 Oct 28, 2016: Hoya Reports Second Quarter Results 222
  • 6.26 Oct 27, 2016: Karolinska Development Portfolio Company Promimic Appoints New Chairman and Directors to its Board 222
  • 6.27 Oct 27, 2016: Stryker reports third quarter 2016 results 223
  • 6.28 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 224
  • 6.29 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results 225
  • 6.30 Oct 26, 2016: Bonesupport Raises USD37 Million in Venture Financing 226
  • 6.31 Oct 26, 2016: Spinal Elements Enters into Distribution Agreement with Mighty Oak Medical 226
  • 6.32 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 226
  • 6.33 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 227
  • 6.34 Oct 25, 2016: Spinal Elements Announces Expansion of Sales Team 228
  • 6.35 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 228
  • 6.36 Oct 25, 2016: NuVasive Reports Third Quarter 2016 Financial Results 229
  • 6.37 Oct 25, 2016: TheraCell and AlloSource Announce Issuance of Patent for Bone Fiber Technology 231
  • 6.38 Oct 20, 2016: CollPlant Files Registration Statement to Raise up to USD25 Million in IPO 231
  • 6.39 Oct 18, 2016: Lattice Biologics Raises USD0.2 Million in Second Tranche of Private Placement of Units 232
  • 6.40 Oct 17, 2016: Orthocell Receives Approval for Human Nerve Regeneration Study Using CelGro 232
  • 6.41 Oct 12, 2016: Adocia Announces Third Quarter 2016 Financial Results 232
  • 6.42 Oct 11, 2016: Xtant Medical Pre-Announces Record Third Quarter 2016 Revenue 234
  • 6.43 Oct 06, 2016: Amedica Provides Business Update 235
  • 6.44 Oct 06, 2016: Medicrea Announces 2016 Third-Quarter Sales 235
  • 6.45 Oct 06, 2016: Xtant Medical Announces the Appointment of Carl O'Connell as President 236
  • 6.46 Oct 05, 2016: Amedica Announces Workforce Reduction 236
  • 6.47 Oct 05, 2016: Alphatec Holdings Announces Company Updates 237
  • 6.48 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 237
  • 6.49 Sep 23, 2016: Spineology Expands Relationship with Nation's Leading Tissue Bank 238
  • 6.50 Sep 22, 2016: Medicrea Announces Results for the 1st Half of 2016 239
  • 6.51 Sep 20, 2016: Exciting addition to the Sr-HT-Gahnite Bone Substitute Project 239
  • 6.52 Sep 19, 2016: RTI Surgical Receives Regulatory Clearances, Expands Distribution of nanOss Bioactive Loaded bone void filler in Australia, Europe 240
  • 6.53 Sep 19, 2016: RTI Surgical Receives CE Mark for nanOss Bioactive 3D bone void filler in Europe 240
  • 6.54 Sep 19, 2016: Cerapedics Raises USD11 Million in Series D Financing 241
  • 6.55 Sep 16, 2016: Federal Circuit Court of Appeals upholds LifeNet Health's $34.7 million patent victory 241
  • 6.56 Sep 15, 2016: Alphatec Holdings Announces Company Updates 241
  • 6.57 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 242
  • 6.58 Sep 15, 2016: Bone Therapeutics receives positive ruling on Belgian Patent Income Deduction 243
  • 6.59 Sep 14, 2016: Nanovis to Raises USD3.8 Million in Venture Financing 244
  • 6.60 Sep 13, 2016: Lattice Biologics Raises USD0.1 Million in First Tranche of Private Placement of Units 244
  • 6.61 Sep 13, 2016: Promimic Raises USD3.2 Million in Venture Financing 244
  • 6.62 Sep 13, 2016: Nanovis Raises USD1.1 Million in Venture Financing 244
  • 6.63 Sep 12, 2016: OssiFi Raises USD0.1 Million in Venture Financing 244
  • 6.64 Sep 12, 2016: NuVasive Names Jason M. Hannon President and Chief Operating Officer; Patrick S. Miles Assumes Role of Vice Chairman 244
  • 6.65 Sep 09, 2016: Cellumed to Raise USD2.7 Million in Public Offering of Bonds 245
  • 6.66 Sep 06, 2016: New Vendor Approval Gives Lattice Biologics Access to 39 Additional Hospitals 245
  • 6.67 Sep 01, 2016: BONESUPPORT's CERAMENT|G Highly Effective Adjunct In The Single Stage Surgical Management Of Chronic Osteomyelitis 246

7 Appendix 351

  • 7.1 Methodology 351
  • 7.2 About GlobalData 354
  • 7.3 Contact Us 354
  • 7.4 Disclaimer 354

List of Tables

  • Table 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 25
  • Table 2: Bone Grafts and Substitutes - Pipeline Products by Segment 26
  • Table 3: Bone Grafts and Substitutes - Pipeline Products by Territory 27
  • Table 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 28
  • Table 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 29
  • Table 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 30
  • Table 7: Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development 31
  • Table 8: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 35
  • Table 9: Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 10: Cartilage Lesions Repair Device - Product Status 39
  • Table 11: Cartilage Lesions Repair Device - Product Description 39
  • Table 12: Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 13: Super-Inductive DBM - Product Status 40
  • Table 14: Super-Inductive DBM - Product Description 40
  • Table 15: Adocia Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 16: BioChaperone BMP - Degenerative Disc Disease - Product Status 41
  • Table 17: BioChaperone BMP - Degenerative Disc Disease - Product Description 42
  • Table 18: Biochaperone BMP - Non-Union Fractures - Product Status 42
  • Table 19: Biochaperone BMP - Non-Union Fractures - Product Description 42
  • Table 20: BioChaperone BMP - Osteoporosis - Product Status 43
  • Table 21: BioChaperone BMP - Osteoporosis - Product Description 43
  • Table 22: Advanced Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 23: OsteoMEM Synthetic Bone Graft Substitute - Product Status 44
  • Table 24: OsteoMEM Synthetic Bone Graft Substitute - Product Description 44
  • Table 25: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 26: BioBone Filler - Product Status 45
  • Table 27: BioBone Filler - Product Description 45
  • Table 28: Agenta Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 29: B-247 Cranial Bone Graft Implant - Product Status 46
  • Table 30: B-247 Cranial Bone Graft Implant - Product Description 46
  • Table 31: Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 32: Sr-HT-Gahnite Bone Substitute - Product Status 47
  • Table 33: Sr-HT-Gahnite Bone Substitute - Product Description 48
  • Table 34: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 35: SeriACL Scaffold - Product Status 49
  • Table 36: SeriACL Scaffold - Product Description 49
  • Table 37: SeriCuff Scaffold - Product Status 50
  • Table 38: SeriCuff Scaffold - Product Description 50
  • Table 39: Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 40: Bonex - Product Status 51
  • Table 41: Bonex - Product Description 51
  • Table 42: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 43: Hyalobone - Product Status 52
  • Table 44: Hyalobone - Product Description 53
  • Table 45: Hyalonect - Product Status 53
  • Table 46: Hyalonect - Product Description 53
  • Table 47: Antibe Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 48: CGX-227 - Product Status 54
  • Table 49: CGX-227 - Product Description 55
  • Table 50: CGX-443 - Product Status 55
  • Table 51: CGX-443 - Product Description 55
  • Table 52: Aperion Biologics Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 53: Z-Fix - Product Status 56
  • Table 54: Z-Fix - Product Description 57
  • Table 55: Z-Lig BT+ - Product Status 57
  • Table 56: Z-Lig BT+ - Product Description 57
  • Table 57: Z-Lig BTB - Product Status 58
  • Table 58: Z-Lig BTB - Product Description 58
  • Table 59: Z-Lig ST - Product Status 58
  • Table 60: Z-Lig ST - Product Description 59
  • Table 61: Z-Meniscus - Product Status 59
  • Table 62: Z-Meniscus - Product Description 59
  • Table 63: Z-Patch - Product Status 60
  • Table 64: Z-Patch - Product Description 60
  • Table 65: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 66: CaReS plus - Product Status 61
  • Table 67: CaReS plus - Product Description 61
  • Table 68: Aursos, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 69: AUR-84 Resorbable Implant - Product Status 62
  • Table 70: AUR-84 Resorbable Implant - Product Description 62
  • Table 71: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 72: INDUCTIGRAFT - Product Status 63
  • Table 73: INDUCTIGRAFT - Product Description 64
  • Table 74: Synthetic Bone Graft - Orthopaedic - Product Status 64
  • Table 75: Synthetic Bone Graft - Orthopaedic - Product Description 64
  • Table 76: Synthetic Bone Graft - Spinal - Product Status 65
  • Table 77: Synthetic Bone Graft - Spinal - Product Description 65
  • Table 78: Berkeley Advanced Biomaterials, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 79: CPA Ceramics - Product Status 66
  • Table 80: CPA Ceramics - Product Description 67
  • Table 81: HAP Ceramics - Product Status 67
  • Table 82: HAP Ceramics - Product Description 68
  • Table 83: Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 84: Hammertoe Intramedullary Fusion Device - Product Status 69
  • Table 85: Hammertoe Intramedullary Fusion Device - Product Description 69
  • Table 86: Bioactive Bone Substitutes Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 87: ARTEBONE - Product Status 70
  • Table 88: ARTEBONE - Product Description 70
  • Table 89: Bone Graft Substitute - Blocks - Product Status 71
  • Table 90: Bone Graft Substitute - Blocks - Product Description 71
  • Table 91: Bone Graft Substitute - Granules - Product Status 71
  • Table 92: Bone Graft Substitute - Granules - Product Description 72
  • Table 93: Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 94: InMotion - Product Status 73
  • Table 95: InMotion - Product Description 73
  • Table 96: Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 97: BMP And Growth Factor Loaded Scaffold - Orthodontic Oral/Maxillofacial Surgery - Product Status 74
  • Table 98: BMP And Growth Factor Loaded Scaffold - Orthodontic Oral/Maxillofacial Surgery - Product Description 75
  • Table 99: BMP And Growth Factor Loaded Scaffold - Orthopaedic Surgery - Product Status 75
  • Table 100: BMP And Growth Factor Loaded Scaffold - Orthopaedic Surgery - Product Description 75
  • Table 101: BMP And Growth Factor Loaded Scaffold - Plastic/Reconstructive Surgery - Product Status 76
  • Table 102: BMP And Growth Factor Loaded Scaffold - Plastic/Reconstructive Surgery - Product Description 76
  • Table 103: BioSET Inc Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 104: AMPLEX Osteo-Promotive Bone Graft System - Foot & Ankle Fusion - Product Status 77
  • Table 105: AMPLEX Osteo-Promotive Bone Graft System - Foot & Ankle Fusion - Product Description 78
  • Table 106: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - Product Status 78
  • Table 107: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - Product Description 78
  • Table 108: Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 109: OsteoAMP - Concentrate - Product Status 79
  • Table 110: OsteoAMP - Concentrate - Product Description 79
  • Table 111: OsteoAMP - Structural - Product Status 80
  • Table 112: OsteoAMP - Structural - Product Description 80
  • Table 113: Bone Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 114: Osteocrete - Bone Anchor - Product Status 81
  • Table 115: Osteocrete - Bone Anchor - Product Description 82
  • Table 116: OsteoCrete - Cranial - Product Status 82
  • Table 117: OsteoCrete - Cranial - Product Description 83
  • Table 118: OsteoCrete - Maxillofacial - Product Status 83
  • Table 119: OsteoCrete - Maxillofacial - Product Description 84
  • Table 120: OsteoCrete - Non Load Bearing Spine - Product Status 84
  • Table 121: OsteoCrete - Non Load Bearing Spine - Product Description 84
  • Table 122: BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 123: Solid Bone Block - Product Status 85
  • Table 124: Solid Bone Block - Product Description 85
  • Table 125: BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 126: Cerament G - Product Status 86
  • Table 127: Cerament G - Product Description 87
  • Table 128: BoneSupport AB - Ongoing Clinical Trials Overview 88
  • Table 129: Cerament G - A Prospective Clinical Outcome Study of a New Biphasic Absorbable Composite Carrier with Gentamicin in the Treatment of Chronic Osteomyelitis 89
  • Table 130: Cerament G - A Prospective, Randomized Multi-center Controlled Trial of CERAMENT G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures 89
  • Table 131: Cerament G - CERAMENT lBONE VOID FILLER and gentamicin eluting CERAMENT lG for Prophylactic Use in Bone Tumor Patients 90
  • Table 132: Cerament G - CERAMENT/G - Bone Healing and Re-infection Prophylaxis 90
  • Table 133: Cerament G - Study to Assess Cerament G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures 90
  • Table 134: Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 135: Corticell - Product Status 91
  • Table 136: Corticell - Product Description 91
  • Table 137: Citrics Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 92
  • Table 138: CitrOSponge - Product Status 92
  • Table 139: CitrOSponge - Product Description 92
  • Table 140: CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 141: VergenixBVF - Antibiotics - Product Status 93
  • Table 142: VergenixBVF - Antibiotics - Product Description 93
  • Table 143: VergenixBVF - rhCollagen - Product Status 94
  • Table 144: VergenixBVF - rhCollagen - Product Description 94
  • Table 145: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 146: Xenograft Implant - Orthopedic - Product Status 95
  • Table 147: Xenograft Implant - Orthopedic - Product Description 95
  • Table 148: ConMed Corporation Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 149: Allograft Cartilage Scaffold - Product Status 96
  • Table 150: Allograft Cartilage Scaffold - Product Description 97
  • Table 151: CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
  • Table 152: Bioactive Bone Graft Substitute - Product Status 98
  • Table 153: Bioactive Bone Graft Substitute - Product Description 98
  • Table 154: curasan AG Pipeline Products & Ongoing Clinical Trials Overview 99
  • Table 155: Cerasorb Classic Ortho - Product Status 99
  • Table 156: Cerasorb Classic Ortho - Product Description 100
  • Table 157: Cerasorb M Ortho - Product Status 100
  • Table 158: Cerasorb M Ortho - Product Description 100
  • Table 159: Cerasorb Ortho Foam - Product Status 101
  • Table 160: Cerasorb Ortho Foam - Product Description 101
  • Table 161: Cerasorb Paste - Product Status 102
  • Table 162: Cerasorb Paste - Product Description 102
  • Table 163: Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 103
  • Table 164: NOVOSIS - Spinal Fusion - Product Status 103

List of Figures

  • Figure 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 25
  • Figure 2: Bone Grafts and Substitutes - Pipeline Products by Segment 26
  • Figure 3: Bone Grafts and Substitutes - Pipeline Products by Territory 27
  • Figure 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 28
  • Figure 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 29
  • Figure 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 30
Back to Top